Skip to content

Author

Leila Hassani

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Mechanistic insights into the interaction of Abamectin and Ivermectin with bovine serum albumin and the protective role of ganoderic acid A: An integrated spectroscopic and in silico study.

It is suggested that ganoderic acid A modulates the interaction of Abamectin and Ivermectin with serum albumin and contributes to preserving protein structural stability under the experimental conditions employed, supporting its potential as a modulator of protein-ligand interactions.

Asma Valizadeh, P. Maghami, Leila Hassani et al. · 0 citations
Review Open access Aug 2026

Therapeutic CRISPR/Cas9 delivery approaches: strengths, limitations, and a roadmap for clinical translation

A major focus of this review is the inclusion of recent hybrid systems (VLPs, SORT-LNPs) and the recognition that chemical modification of guide RNAs is a critical parameter for therapeutic success and that hybrid systems and stimuli-responsive nanoparticles are poised to dominate the next 5 years of clinical developme...

M. Rezaee, F. Izadi, Saeed Nobaharian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.